纳米探针
吲哚青绿
体内
衰老
离体
癌细胞
癌症研究
癌症
化学
临床前影像学
荧光寿命成像显微镜
生物相容性材料
细胞生物学
荧光
医学
纳米技术
生物医学工程
材料科学
病理
生物
内科学
生物技术
纳米颗粒
物理
量子力学
作者
Andrew Baker,Muhamad Hartono,Hui‐Ling Ou,Andrea Bistrović,Emma Brown,James Joseph,Monika Golinska,Estela González‐Gualda,David Macías,Jianfeng Ge,Mary Denholm,Samir Morsli,Chandan Sanghera,Thomas R. Else,Heather F. Greer,Aude Vernet,Sarah E. Bohndiek,Daniel Muñoz‐Espín,Ljiljana Fruk
标识
DOI:10.1002/anie.202404885
摘要
There is an urgent need to improve conventional cancer-treatments by preventing detrimental side effects, cancer recurrence and metastases. Recent studies have shown that presence of senescent cells in tissues treated with chemo- or radiotherapy can be used to predict the effectiveness of cancer treatment. However, although the accumulation of senescent cells is one of the hallmarks of cancer, surprisingly little progress has been made in development of strategies for their detection in vivo. To address a lack of detection tools, we developed a biocompatible, injectable organic nanoprobe (NanoJagg), which is selectively taken up by senescent cells and accumulates in the lysosomes. The NanoJagg probe is obtained by self-assembly of indocyanine green (ICG) dimers using a scalable manufacturing process and characterized by a unique spectral signature suitable for both photoacoustic tomography (PAT) and fluorescence imaging. In vitro, ex vivo and in vivo studies all indicate that NanoJaggs are a clinically translatable probe for detection of senescence and their PAT signal makes them suitable for longitudinal monitoring of the senescence burden in solid tumors after chemotherapy or radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI